A large pharmaceutical player sought oncology ventures that could offer advice, patient cohorts, or clinical trials capabilities, in LATAM, Middle East & Asia
Leveraging the unmatched breadth of our worldwide HealthTech Alpha database, combined with Scouting, we were able to pinpoint micro data points (oncology focused ventures, clinical trials) in target markets to build the client a highly prioritised target list of 17 ventures for further evaluation
| Number of countries | 8 |
| Number of Key TAs analysed | 1 |
| Number of ventures screened | 113 |
| Number of ventures shortlisted | 17 |
Contact us to explore how your organisation can fast track its Digital Health strategy with Galen Growth
